Ethyl 7-Oxo-7-Phenylheptanoate Synthesis Route & Specs
WO2003004450A1 Patent Compliance for Ethyl 7-Oxo-7-Phenylheptanoate Synthesis Routes
The manufacturing of Ethyl 7-Oxo-7-Phenylheptanoate (CAS: 112665-41-5) requires precise control over carbon chain extension and keto-ester functionality. In the context of statin intermediate production, synthesis routes often reference methodologies similar to those described in WO2003004450A1. Our engineering team focuses on the chemical alignment of these processes, specifically regarding the acylation of aromatic substrates and subsequent esterification steps. While intellectual property landscapes vary by region, the technical execution involves careful management of reaction exotherms during the Friedel-Crafts or Grignard-type additions commonly associated with this chemical class.
From a process chemistry perspective, maintaining the integrity of the 7-oxo group is critical. During scale-up, we observe that trace acidic impurities can catalyze unwanted enolization, affecting downstream coupling efficiency. At NINGBO INNO PHARMCHEM CO.,LTD., we optimize reaction temperatures to minimize thermal degradation thresholds, ensuring the synthesis route yields a stable intermediate suitable for further pharmaceutical processing. This approach mirrors the rigorous standards expected for high-value pharmaceutical intermediate supply.
Pharmaceutical Grade Purity Specifications: HPLC Assay and Impurity Profiles
Quality assurance for 7-oxo-7-phenyl-heptanoic acid ethyl ester relies on robust analytical methods. We utilize High-Performance Liquid Chromatography (HPLC) to determine the main assay and quantify related substances. The target purity for pharmaceutical applications typically exceeds 98.0%, though specific project requirements may dictate tighter controls. Impurity profiling focuses on detecting unreacted starting materials, such as benzoic acid derivatives or over-acylated byproducts.
Our internal specifications differentiate between standard industrial grades and custom high purity batches intended for GMP synthesis. The table below outlines typical technical parameters compared against standard market expectations:
| Parameter | Standard Industrial Grade | Pharmaceutical Grade (Typical) | Test Method |
|---|---|---|---|
| Assay (HPLC) | > 95.0% | > 98.5% | Area Normalization |
| Single Impurity | < 1.0% | < 0.5% | HPLC |
| Total Impurities | < 2.0% | < 1.0% | HPLC |
| Appearance | Yellowish Oil | Colorless to Pale Yellow | Visual |
For precise data on a specific lot, please refer to the batch-specific COA. Variations in ethyl 6-benzoyl-hexanoate analogues or isomeric byproducts are monitored closely to ensure compatibility with downstream hydrogenation or reduction steps.
Critical COA Parameters: Residual Solvents, Heavy Metals, and Water Content Limits
Beyond the main assay, the Certificate of Analysis (COA) must account for process-related impurities. Based on common synthesis protocols involving solvents like Toluene, Ethyl Acetate, or THF (as seen in related patent literature such as CN101265188A), residual solvent analysis is mandatory. We adhere to ICH Q3C guidelines where applicable for pharmaceutical supply chains.
Key parameters monitored include:
- Water Content: Typically controlled via Karl Fischer titration to prevent hydrolysis of the ester moiety during storage. Limits are generally set below 0.5%.
- Heavy Metals: Screened to ensure compliance with downstream catalyst sensitivity, often required < 10 ppm for specific coupling reactions.
- Residual Solvents: Class 2 and Class 3 solvents are quantified using Headspace GC. Common residuals include Toluene and Ethyl Acetate.
Controlling these parameters is essential for maintaining the stability of the organic synthesis pathway. High water content, for instance, can accelerate degradation during long-term storage, particularly in non-climate-controlled environments.
GMP-Compliant Bulk Packaging Solutions for Statin Intermediate Supply Chain
Physical packaging integrity is as crucial as chemical purity. For bulk shipments of Ethyl 7-Oxo-7-Phenylheptanoate, we utilize chemically resistant containers to prevent interaction with the container lining. Standard options include 210L carbon steel drums with phenolic epoxy lining or IBC totes for larger volumes.
Our logistics team ensures that all packaging is sealed under nitrogen padding where necessary to exclude moisture and oxygen. This is particularly important for keto-esters that may be sensitive to oxidative degradation. We focus strictly on physical packaging specifications and factual shipping methods to ensure the product arrives in the same condition it left the facility. All packaging materials are selected to withstand the physical stresses of international freight without compromising the container's seal.
Batch Consistency and Stability Data for R&D Scale-Up Validation
For R&D managers planning scale-up, batch-to-batch consistency is the primary metric for validation. We maintain historical data on reaction yields and impurity profiles to predict performance in larger vessels. A critical non-standard parameter we monitor is the viscosity shift at sub-zero temperatures. During winter shipping or cold storage, this intermediate can exhibit increased viscosity or slight crystallization tendencies, which affects pumping rates during bulk transfer.
We recommend maintaining storage temperatures above 10°C to ensure free-flowing characteristics. This field knowledge helps prevent bottlenecks during unloading and transfer into reactor vessels. Stability studies indicate that when stored in original sealed containers away from direct sunlight, the material retains specification for up to 24 months. For custom synthesis projects, we can provide accelerated stability data to support your registration filings.
Frequently Asked Questions
What is the typical lead time for bulk orders?
Standard lead times vary based on current production schedules and inventory levels. Please contact our sales team for a specific timeline regarding tonnage availability.
Can you provide a sample for R&D testing?
Yes, we support R&D efforts with sample quantities. Technical specs and safety data will accompany the sample shipment for your evaluation.
What documentation is provided with shipment?
Every shipment includes a Certificate of Analysis (COA), Safety Data Sheet (SDS), and packing list. Additional documentation can be arranged based on commercial agreements.
Do you offer custom packaging configurations?
Yes, we can accommodate specific packaging requirements such as smaller drum sizes or specialized lining based on project needs and minimum order quantities.
Sourcing and Technical Support
Securing a reliable supply of critical statin intermediates requires a partner with deep technical expertise and robust manufacturing capabilities. NINGBO INNO PHARMCHEM CO.,LTD. is committed to delivering consistent quality and transparent technical data to support your production goals. We invite you to review our detailed product specifications via our Ethyl 7-Oxo-7-Phenylheptanoate manufacturer page for further information. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.